img

Global Anti-inflammatory Therapy Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-inflammatory Therapy Market Research Report 2024

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
According to Mr Accuracy reports new survey, global Anti-inflammatory Therapy market is projected to reach US$ 168750 million in 2029, increasing from US$ 110540 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-inflammatory Therapy market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-inflammatory Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Segment by Type
Corticosteroids
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs
Others

Segment by Application


Respiratory Diseases
Arthritis
Gastroenterology
Dermatology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Anti-inflammatory Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Corticosteroids
1.2.3 Anti-inflammatory Biologics
1.2.4 Non-Steroidal Anti-inflammatory Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Respiratory Diseases
1.3.3 Arthritis
1.3.4 Gastroenterology
1.3.5 Dermatology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapy Market Perspective (2018-2029)
2.2 Anti-inflammatory Therapy Growth Trends by Region
2.2.1 Global Anti-inflammatory Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anti-inflammatory Therapy Historic Market Size by Region (2018-2024)
2.2.3 Anti-inflammatory Therapy Forecasted Market Size by Region (2024-2029)
2.3 Anti-inflammatory Therapy Market Dynamics
2.3.1 Anti-inflammatory Therapy Industry Trends
2.3.2 Anti-inflammatory Therapy Market Drivers
2.3.3 Anti-inflammatory Therapy Market Challenges
2.3.4 Anti-inflammatory Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapy Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapy Players by Revenue (2018-2024)
3.1.2 Global Anti-inflammatory Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Anti-inflammatory Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-inflammatory Therapy Revenue
3.4 Global Anti-inflammatory Therapy Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapy Revenue in 2022
3.5 Anti-inflammatory Therapy Key Players Head office and Area Served
3.6 Key Players Anti-inflammatory Therapy Product Solution and Service
3.7 Date of Enter into Anti-inflammatory Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapy Breakdown Data by Type
4.1 Global Anti-inflammatory Therapy Historic Market Size by Type (2018-2024)
4.2 Global Anti-inflammatory Therapy Forecasted Market Size by Type (2024-2029)
5 Anti-inflammatory Therapy Breakdown Data by Application
5.1 Global Anti-inflammatory Therapy Historic Market Size by Application (2018-2024)
5.2 Global Anti-inflammatory Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anti-inflammatory Therapy Market Size (2018-2029)
6.2 North America Anti-inflammatory Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Anti-inflammatory Therapy Market Size by Country (2018-2024)
6.4 North America Anti-inflammatory Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapy Market Size (2018-2029)
7.2 Europe Anti-inflammatory Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Anti-inflammatory Therapy Market Size by Country (2018-2024)
7.4 Europe Anti-inflammatory Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapy Market Size (2018-2029)
8.2 Asia-Pacific Anti-inflammatory Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2018-2024)
8.4 Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-inflammatory Therapy Market Size (2018-2029)
9.2 Latin America Anti-inflammatory Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Anti-inflammatory Therapy Market Size by Country (2018-2024)
9.4 Latin America Anti-inflammatory Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapy Market Size (2018-2029)
10.2 Middle East & Africa Anti-inflammatory Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2018-2024)
10.4 Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapy Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapy Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Detail
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapy Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Detail
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapy Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Detail
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapy Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapy Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapy Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Detail
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapy Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapy Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapy Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Detail
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Detail
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapy Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapy Business (2018-2024)
11.12.5 TEVA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anti-inflammatory Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Anti-inflammatory Biologics
Table 4. Key Players of Non-Steroidal Anti-inflammatory Drugs
Table 5. Key Players of Others
Table 6. Global Anti-inflammatory Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Anti-inflammatory Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Anti-inflammatory Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Anti-inflammatory Therapy Market Share by Region (2018-2024)
Table 10. Global Anti-inflammatory Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Anti-inflammatory Therapy Market Share by Region (2024-2029)
Table 12. Anti-inflammatory Therapy Market Trends
Table 13. Anti-inflammatory Therapy Market Drivers
Table 14. Anti-inflammatory Therapy Market Challenges
Table 15. Anti-inflammatory Therapy Market Restraints
Table 16. Global Anti-inflammatory Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Anti-inflammatory Therapy Market Share by Players (2018-2024)
Table 18. Global Top Anti-inflammatory Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2022)
Table 19. Ranking of Global Top Anti-inflammatory Therapy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anti-inflammatory Therapy Product Solution and Service
Table 23. Date of Enter into Anti-inflammatory Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-inflammatory Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Anti-inflammatory Therapy Revenue Market Share by Type (2018-2024)
Table 27. Global Anti-inflammatory Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Anti-inflammatory Therapy Revenue Market Share by Type (2024-2029)
Table 29. Global Anti-inflammatory Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Anti-inflammatory Therapy Revenue Market Share by Application (2018-2024)
Table 31. Global Anti-inflammatory Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Anti-inflammatory Therapy Revenue Market Share by Application (2024-2029)
Table 33. North America Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Anti-inflammatory Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 35. North America Anti-inflammatory Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Anti-inflammatory Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 38. Europe Anti-inflammatory Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Anti-inflammatory Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 41. Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Anti-inflammatory Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Latin America Anti-inflammatory Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 47. Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie Anti-inflammatory Therapy Product
Table 51. AbbVie Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Johnson & Johnson Company Detail
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Anti-inflammatory Therapy Product
Table 56. Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. Amgen Inc Company Detail
Table 59. Amgen Inc Business Overview
Table 60. Amgen Inc Anti-inflammatory Therapy Product
Table 61. Amgen Inc Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 62. Amgen Inc Recent Development
Table 63. AstraZeneca PLC Company Detail
Table 64. AstraZeneca PLC Business Overview
Table 65. AstraZeneca PLC Anti-inflammatory Therapy Product
Table 66. AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 67. AstraZeneca PLC Recent Development
Table 68. Pfizer, Inc Company Detail
Table 69. Pfizer, Inc Business Overview
Table 70. Pfizer, Inc Anti-inflammatory Therapy Product
Table 71. Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 72. Pfizer, Inc Recent Development
Table 73. Novartis Company Detail
Table 74. Novartis Business Overview
Table 75. Novartis Anti-inflammatory Therapy Product
Table 76. Novartis Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Roche Company Detail
Table 79. Roche Business Overview
Table 80. Roche Anti-inflammatory Therapy Product
Table 81. Roche Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Merck Company Detail
Table 84. Merck Business Overview
Table 85. Merck Anti-inflammatory Therapy Product
Table 86. Merck Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Sanofi Company Detail
Table 89. Sanofi Business Overview
Table 90. Sanofi Anti-inflammatory Therapy Product
Table 91. Sanofi Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. GlaxoSmithKline Company Detail
Table 94. GlaxoSmithKline Business Overview
Table 95. GlaxoSmithKline Anti-inflammatory Therapy Product
Table 96. GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 97. GlaxoSmithKline Recent Development
Table 98. Sun Pharmaceutical Industries Ltd Company Detail
Table 99. Sun Pharmaceutical Industries Ltd Business Overview
Table 100. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Product
Table 101. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 102. Sun Pharmaceutical Industries Ltd Recent Development
Table 103. TEVA Company Detail
Table 104. TEVA Business Overview
Table 105. TEVA Anti-inflammatory Therapy Product
Table 106. TEVA Revenue in Anti-inflammatory Therapy Business (2018-2024) & (US$ Million)
Table 107. TEVA Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-inflammatory Therapy Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Anti-inflammatory Therapy Market Share by Type: 2022 VS 2029
Figure 3. Corticosteroids Features
Figure 4. Anti-inflammatory Biologics Features
Figure 5. Non-Steroidal Anti-inflammatory Drugs Features
Figure 6. Others Features
Figure 7. Global Anti-inflammatory Therapy Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Anti-inflammatory Therapy Market Share by Application: 2022 VS 2029
Figure 9. Respiratory Diseases Case Studies
Figure 10. Arthritis Case Studies
Figure 11. Gastroenterology Case Studies
Figure 12. Dermatology Case Studies
Figure 13. Others Case Studies
Figure 14. Anti-inflammatory Therapy Report Years Considered
Figure 15. Global Anti-inflammatory Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Anti-inflammatory Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Anti-inflammatory Therapy Market Share by Region: 2022 VS 2029
Figure 18. Global Anti-inflammatory Therapy Market Share by Players in 2022
Figure 19. Global Top Anti-inflammatory Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapy Revenue in 2022
Figure 21. North America Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Anti-inflammatory Therapy Market Share by Country (2018-2029)
Figure 23. United States Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Anti-inflammatory Therapy Market Share by Country (2018-2029)
Figure 27. Germany Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Anti-inflammatory Therapy Market Share by Region (2018-2029)
Figure 35. China Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Anti-inflammatory Therapy Market Share by Country (2018-2029)
Figure 43. Mexico Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Anti-inflammatory Therapy Market Share by Country (2018-2029)
Figure 47. Turkey Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Anti-inflammatory Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. AbbVie Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 51. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 52. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 53. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 54. Novartis Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 55. Roche Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 56. Merck Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 57. Sanofi Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 59. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 60. TEVA Revenue Growth Rate in Anti-inflammatory Therapy Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed